Bio-Rad Laboratories, Inc. (BIO)

539.65 0.80%
03:19 pm EDT; Powered by IEX
Forward P/B ratio low relative to industry peers
Buy analyst rating
Average analyst stock price above current stock price
Revenue growth lower than the industry and sector averages
Company’s profitability is declining
Forward P/E ratio high relative to industry peers


  1. BIO Price/Book ratio is 1.10, which is low compared to its industry peers’ P/B ratios. See BIO forward Price/Book ratio chart.
  2. BIO average analyst rating is Buy. See BIO analyst rating chart.
  3. BIO average analyst price target ($700.00) is above its current price ($553.61). See BIO price target chart.


  1. BIO quarterly revenue growth was -3.70%, lower than the industry and sector average revenue growth (11.23% and 7.51%, respectively). See BIO revenue growth chart.
  2. BIO profitability is declining. The YoY profit margin change was -73.44 percentage points. See BIO profitability chart.
  3. BIO forward P/E ratio is 41.63, which is high compared to its industry peers’ P/E ratios. See BIO forward P/E ratio chart.